The company develops and commercializes GPX-002 and maintains oncology clinical development programs and pipeline assets. Its ONCOPREX Delivery System is designed to deliver therapeutic and prophylactic plasmid DNA and RNA interference constructs, with potential applications in cancers beyond lung cancer. REQORSA, administered via ONCOPREX, has demonstrated tolerability and efficacy in human studies. Collaborators at MD Anderson Cancer Center have conducted preclinical research identifying biomarkers TROP2 and PTEN as predictors of response to REQORSA in non-small cell lung cancer (NSCLC). Additional studies indicate that TUSC2 delivered through Quar Oze enhances innate antitumor immunity and inhibits tumor progression. The company holds licensed rights to the tumor suppressor gene TUSC2 and other tumor suppressor genes located on human Chromosome 3p21.3. Researchers at MD Anderson are conducting preclinical studies on these genes to evaluate their potential in cancer treatment. MD Anderson is a named customer and collaborator in the company's filings.

Genprex Inc’s Comment on Sales, Marketing and Customers

GNPX's Stock Performance relative to it's Customers

GNPX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Genprex Inc	1.60	0.00	-16.73	13
SUBTOTAL	0.00	0.00	0.00	-

Sources: Genprex Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Genprex Inc’s corporate clients.
For your research, we’ve provided 9 tables on Genprex Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.